Huang Yu-hua, MD/PhD, is currently an associate professor in the Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China. He specializes in lymphoid pathology. Dr. Huang has been a visiting scholar at the Prince of Wales hospital, the Chinese University of Hong Kong and the University of Nebraska Medical Center (UNMC), USA. He is a committee member of the Lymphoma Group, the Pathology Branch of the Chinese anti-cancer association (CACA) and thr CCPI. He is a recipient of the Outstanding Young Pathologist of the Wu Bing-quan Education Foundation, China. Dr. Huang’s primary research interests include the pathological and transnational research on EBV-associated malignancies, including lymphoma and EBV-associated cholangiocarcinoma. He has published more than 40 peer-reviewed papers, including papers in renowned journals such as the Journal of Hepatology, the American Journal of Surgical Pathology, the International Journal of Cancer, and Histopathology.

Lymphoid pathology; pathological and translational studies on EBV-associated cholangiocarcinoma.

B.D., Sun Yat-sen University, China, 2001-2006.

M.D. in Oncology, Sun Yat-sen University, China, 2006-2009.

Ph.D in Oncology, Sun Yat-sen University, China, 2017-2020.

Selected publications

1. Huang YH#, Zhang Chris ZY#, Huang QS#, Yeong J,Wang F, Yang X, He YF, Zhang XL,Zhang H,Chen SL, Zheng YL, Deng R, Lin CS, Yang MM, Li Y, Jiang C, Lee T KW, Ma S, Zeng MS, Yun JP*. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma, Journal of Hepatology, 2021 (74): 838-849.

2. Huang YH, Shi XL, Zhong P, Wang Y, Xiao HL, Zhou XG, Yun JP: De Novo Testicular Extranodal NK/T-Cell Lymphoma: A Clinicopathologic Study of 21 Cases With Review of Additional 18 Cases in the Literature. Am J Surg Pathol 2019, 43(4):549-558.

3. Zhang JJ, Luo XY,Huang QT, Huang YH*.Clinicopathological and prognostic features of nasopharyngeal carcinoma in children and adolescents: A retrospective study of 196 cases in South China, International Journal of Cancer, 2021, 148(5): 1087-1096.

4. Miao LF, Guo N, Feng YF, Rao HL, Wang F, Huang QT, Huang YH*. High Incidence of MYC Rearrangement in HIV-Positive Plasmablastic Lymphoma. Histopathology 2020, 76, 201–211.

5. Huang YH#, Rao HL#, Yan SM, Wang F, Wu QN, Feng YF, Zhang YJ*. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution. Ann Hematol 2017, 96(8):1331-1342. 

6. Chen SL#, Huang QS#, Huang YH#,Yang X, Yang MM, He YF,Yun C, Guan XY,Yun JP*. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-kappa B pathway in Clear Cell Renal Carcinoma, Theranostics, 2020, 10(20): 9186-9199. 

7. Tao LL#, Huang YH#, Chen YL, Yu GY, Yin WH: SSTR2a Is a Useful Diagnostic Marker for Follicular Dendritic Cells and Their Related Tumors. Am J Surg Pathol 2019, 43(3):374-381. 

8. Huang YH, Luo MH, Ni YB, Tsang JY, Chan SK, Lui PC, Yu AM, Tan PH, Tse GM: Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases. Histopathology 2014, 64(4):494-503.

9. Huang YH, Yan SM, Liu LL, Lu JB, Yang X, He YF, Yun JP. Incidental lymphoma in lymph node dissection for carcinoma in the abdominopelvic cavity: a single-institution experience. Virchows Arch 2019, 475(3):365-372.

10. Huang YH, Chen SL,  Wei R,  Guo XJ, Yang X,  Cao QC, Yang Y,  Yun JP. CD20-positive Extranodal NK/T-cell Lymphoma: Clinicopathologic and Prognostic Features. Virchows Arch.2020.477(6):873-883

Updated March 2021 by International Office, Sun Yat-sen University Cancer Center